logo

For the Inventor, By the Inventor

Nottinghamshire, United Kingdom

Kenneth J Nichol

This inventor holds 10 USPTO granted patents. Top assignee: The Boots Company Plc. Active years: 1976-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth J Nichol. Retrieved from https://idiyas.com/inventor/kenneth-j-nichol

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 7

Forward Citations = 86(Granted Patents)


Location History:

  • Nottingham, EN (1976 - 1978)
  • West Bridgford, GB (1978)
  • boht of Nottinghamshire, GB (1991)
  • Nottinghamshire, GB (1992)
  • Nottingham, GB (1981 - 1996)

Company Filing History:

goldMedal10 out of 172 
 
The Boots Company Plc
 patents

Years Active: 1976-1996

Loading Chart...
10 patents (USPTO):Explore Patents
1. 5580866 - Therapeutic 1,4-thiazepines (1996-12-03),
2. 5079264 - Chemical process (1992-01-07),
3. 5011931 - Process for the preparation of 1-methyl-3-methylthio-4-quinolone and the (1991-04-30),
4. 4772614 - Quinolone sulphonamides useful as antihypertensive agents (1988-09-20),
5. 4302460 - 4-Quinolinones having antihypertensive activity (1981-11-24),
6. 4120960 - Therapeutic agents (1978-10-17),
7. 4081540 - 1-Morpholinocarbonyl imidazoles (1978-03-28),
8. 4048188 - 1-Carbonamido imidazoles (1977-09-13),
9. 3996366 - Thio derivatives of imidazol-1-yl carboxamides (1976-12-07),
10. 3940484 - Insecticidal compositions and methods of combatting insects using (1976-02-24),

Title: Inventor Kenneth J. Nichol: A Pioneer in Cardiovascular Agent Development

Introduction

Kenneth J. Nichol, a prominent inventor based in Nottinghamshire, Great Britain, has made significant contributions to the field of chemical processes and pharmaceuticals. With a portfolio of 10 patents, he has focused primarily on innovations in therapeutic compounds aimed at improving cardiovascular health.

Latest Patents

One of Nichol's latest patents is titled "Therapeutic 1,4-thiazepines - Chemical process." This patent outlines a unique method for preparing compounds of a specific formula through the cyclization of precursors. The process can be executed in the presence of either an organic or inorganic base or through thermal means at temperatures ranging from 40°C to 160°C. The compounds disclosed, along with their analogues, are recognized as potential cardiovascular agents, showcasing Nichol's commitment to advancing medical science.

Career Highlights

Kenneth J. Nichol has established himself as a leading inventor at The Boots Company Plc, an organization known for its innovative healthcare products and services. His work in developing chemicals that could lead to new therapeutic avenues has been instrumental in enhancing the company's research portfolio and expanding its impact in the pharmaceutical industry.

Collaborations

Throughout his career, Nichol has collaborated with esteemed colleagues, including Maurice W. Baker and John C. Kerry. These partnerships have facilitated the exchange of ideas and expertise, contributing to the successful development of innovative solutions in his field.

Conclusion

Kenneth J. Nichol stands out as an influential figure in the realm of chemical innovation, particularly in the development of cardiovascular agents. His numerous patents and collaborations highlight his dedication to advancing healthcare through innovative research and practical applications. As the industry continues to evolve, Nichol's contributions remain pivotal in shaping the future of pharmaceuticals and enhancing the well-being of patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…